Validation of the ELISA Method for Quantitative Detection of TNF-α in Patients with Intracerebral Hemorrhage

Authors

  • Vladimir Rendevski University Clinic for Neurosurgery, Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje
  • Boris Aleksovski Faculty of Natural Sciences and Mathematics, Ss Cyril and Methodius University of Skopje, Skopje
  • Dragan Stojanov Center of Radiology, Clinical Center NiÅ¡, Faculty of Medicine, University of NiÅ¡, NiÅ¡
  • Ana Mihajlovska-Rendevska University Clinic for Radiology, Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje
  • Vasko Aleksovski University Clinic for Neurology, Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje
  • Natalija Baneva–Dolnenec University Clinic for Neurology, Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje
  • Dijana Nikodijevic University Clinic for Neurology, Medical Faculty, Ss Cyril and Methodius University of Skopje, Skopje
  • Dance Gudeva-Nikovska Ministry of Health, Global Fund, Skopje

DOI:

https://doi.org/10.3889/oamjms.2017.170

Keywords:

TNF-α, intracerebral haemorrhage, ELISA, standard addition, spectroscopy

Abstract

AIM: We aimed to investigate the sensitivity, reproducibility and validity of the commercial ELISA kits for quantitative detection of TNF-α and their potential application for screening purposes in patients with ICH.

METHODS: Analysis of six independent standard series, evaluation of the deviation of the TNF-α concentration in patients with ICH, standard addition and visual analysis of whole UV-Vis spectra were carefully performed.

RESULTS: Low standard deviations of the absorbance were detected for every standard, as well as in the samples of healthy controls and patients with ICH. The standard addition series have also confirmed high sensitivity and reproducibility of the assay, with a congruent shift of the standard curves with the concentration of TNF-α for the added plasma. The visual analyses of the gained spectra have revealed the absence of any matrix effects from the addition of the human plasma in the reconstituted standards.

CONCLUSION: The commercial ELISA kits can be used in the clinical practice for screening purposes of the plasma TNF-α levels in patients with ICH.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Esposito E and Cuzzocrea S. TNF-Alpha as a Therapeutic Target in Inflammatory Diseases. Ischemia- Reperfusion Injury and Trauma. Curr Med Chem. 2009; 16(24): 3152–67. https://doi.org/10.2174/092986709788803024 PMid:19689289

Matsuno H. Yudoh K. Katayama R. Nakazawa F. Uzuki M. Sawai T. Yonezawa T. Saeki Y. Panayi GS. Pitzalis C. Kimura T. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera. Rheumatology (Oxford). 2002;41(3):329-37. https://doi.org/10.1093/rheumatology/41.3.329

Swaroop JJ. Rajarajeswari D. Naidu JN. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. The Indian Journal of Medical Research. 2012;135(1):127-130. https://doi.org/10.4103/0971-5916.93435 PMid:22382194 PMCid:PMC3307173

Kleinbongard P. Heusch G. Schulz R. TNFalpha in atherosclerosis. myocardial schemia/ reperfusion and heart failure. Pharmacol Ther. 2010;127(3):295-314. https://doi.org/10.1016/j.pharmthera.2010.05.002 PMid:20621692

van Horssen R. Ten Hagen TL. Eggermont AM. TNF-alpha in cancer treatment: molecular insights. antitumor effects. and clinical utility. Oncologist. 2006;11(4):397-408. https://doi.org/10.1634/theoncologist.11-4-397 PMid:16614236

Frankola KA. Greig NH. Luo W. Tweedie D. Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2011;10(3):391-403. https://doi.org/10.2174/187152711794653751 PMid:21288189 PMCid:PMC4663975

Bruunsgaard H. Skinhøj P. Pedersen AN. Schroll M. Pedersen BK. Ageing. tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol. 2000;121(2):255-60. https://doi.org/10.1046/j.1365-2249.2000.01281.x PMid:10931139 PMCid:PMC1905691

Behrouz R. Re-exploring Tumor Necrosis Factor Alpha as a Target for Therapy in Intracerebral Hemorrhage. Transl Stroke Res. 2016;7(2):93-6. https://doi.org/10.1007/s12975-016-0446-x PMid:26762364

McCoy MK. Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. Journal of Neuroinflammation. 2008;5:45. https://doi.org/10.1186/1742-2094-5-45 PMid:18925972 PMCid:PMC2577641

Vakili A. Mojarrad S. Akhavan MM. Rashidy-Pour A. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats. Brain Res. 2011;1377:119–25. https://doi.org/10.1016/j.brainres.2011.01.001 PMid:21219888

Huang LQ. Zhu GF. Deng YY. Jiang WQ. Fang M. Chen CB. et al. Hypertonic saline alleviates cerebral edema by inhibiting microgliaderived TNF-α and IL-1β-induced Na-K-Cl cotransporter up-regulation. J Neuroinflammation. 2014;11:102. https://doi.org/10.1186/1742-2094-11-102 PMid:24916922 PMCid:PMC4080704

Gebel JM Jr. Jauch EC. Brott TG. Khoury J. Sauerbeck L. Salisbury S. Spilker J. Tomsick TA. Duldner J. Broderick JP. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002;33(11):2636-41. https://doi.org/10.1161/01.STR.0000035283.34109.EA

Olmos G. Llado J. Tumor necrosis factor Alpha: A link between Neuroinflammation and Excitotoxicity. Mediators of Inflammation. 2014; 2014: 861231. https://doi.org/10.1155/2014/861231 PMid:24966471 PMCid:PMC4055424

Silva Y. Leira R. Tejada J. Lainez JM. Castillo J. Davalos A: Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86-91. https://doi.org/10.1161/01.STR.0000149615.51204.0b PMid:15550687

Zhang XM. Li XL. Tang SH. Liu QC. Effect of head hypothermia on serum inflammatory cytokines levels in patients with hypertensive intracerebral hemorrhage. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006; 18(5):294–296. PMid:16700996

Hua Y. Wu J. Keep RF. Nakamura T. Hoff JT. Xi G. Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery. 2006;58:542–5. https://doi.org/10.1227/01.NEU.0000197333.55473.AD PMid:16528196

Castillo J. Dávalos A. Alvarez-Sabín J. Pumar JM. Leira R. Silva Y. Montaner J. Kase CS. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002 26;58(4):624-9.

Yang G. Shao GF. Elevated serum IL-11. TNF α. and VEGF expressions contribute to the pathophysiology of hypertensive intracerebral hemorrhage (HICH). Neurol Sci. 2016;37(8):1253-9. https://doi.org/10.1007/s10072-016-2576-z PMid:27115896

Farney JK. Mamedova LK. Godsey BH. Bradford BJ. Technical note: validation of an ELISA for measurement of tumor necrosis factor alpha in bovine plasma. J Dairy Sci. 2011;94(7):3504-9. https://doi.org/10.3168/jds.2010-4082 PMid:21700038

Creve S. Validation of the analytical methods for the detection of cytokines in the early stages of heart failure. Master thesis. Ghent University. Faculty of Pharmaceutical Sciences. Ghent. 2010.

Published

2017-09-22

How to Cite

1.
Rendevski V, Aleksovski B, Stojanov D, Mihajlovska-Rendevska A, Aleksovski V, Baneva–Dolnenec N, Nikodijevic D, Gudeva-Nikovska D. Validation of the ELISA Method for Quantitative Detection of TNF-α in Patients with Intracerebral Hemorrhage. Open Access Maced J Med Sci [Internet]. 2017 Sep. 22 [cited 2024 Mar. 28];5(6):703-7. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2017.170

Issue

Section

A - Basic Science

Most read articles by the same author(s)